良民是什么意思| 八月十五什么星座| 竖中指是什么意思| 蓉字五行属什么| 吃什么食物补血| 酒后手麻什么原因| 约炮什么意思| 舌苔白有齿痕吃什么药| 夜间胃痛是什么原因| 宝宝辅食虾和什么搭配| 形影不离是什么意思| 吃完饭就想睡觉是什么原因| 饱和什么意思| haglofs是什么牌子| 木棉是什么面料| 良辰吉日什么意思| 27属什么| 五行大林木是什么意思| 前列腺炎是什么原因引起的| 臭粉是什么东西| 夏天煲什么汤| 花千骨什么时候上映的| 买什么样的老花镜好| 小猫起什么名字好听| 相亲第一次见面送什么礼物好| 小孩下半夜咳嗽是什么原因| 祛湿吃什么食物| yuri是什么意思| 基底是什么意思| 什么叫闭合性跌打损伤| 梦见烧纸钱是什么意思| 高嘌呤是什么意思| 三湖慈鲷可以和什么鱼混养| 额头老出汗是什么原因| lyocell是什么面料| 什么的雨| 什么是假性银屑病| 小孩吃榴莲有什么好处| 奶酪是什么| 音召念什么| burberry什么牌子| 执业药师证有什么用| 深沉是什么意思| 沉鱼落雁闭月羞花什么意思| 小肝功能是检查什么| 火可以加什么偏旁| 什么是过敏体质| 人为什么会发烧| hs医学上是什么意思| trx是什么| 信口雌黄是什么意思| karen是什么意思| 李约瑟难题是什么| 孕期阴道炎可以用什么药| 深渊什么意思| 灯红酒绿是什么意思| 肝脂肪浸润是什么意思| 流产的血是什么颜色| 产后为什么脸部松弛| 精神寄托是什么意思| 什么叫免疫组化| 长期尿黄可能是什么病| 吃什么东西增加免疫力| 什么什么一什么| 妈妈的爸爸叫什么| 喝什么能补肾| 什么是巨细胞病毒| 活检是什么检查| 麸皮是什么东西| od值是什么意思| ap医学上是什么意思| 什么是冷战| 忍辱负重是什么意思| 胎儿畸形是什么原因造成的| 大驿土是什么意思| 东南大学什么专业最牛| 来大姨妈能喝什么饮料| 凯撒是什么意思| r0lex是什么牌子手表| 一直放臭屁是什么原因| 自卑是什么意思| 瘢痕是什么意思| 什么时候跑步减肥效果最好| 三加一是什么意思| 吃什么对心脏好| 胸小是缺少什么营养| 孕妇早上吃什么早餐好| 小孩血压高是什么原因| 怀疑甲亢需要做什么检查| 支气管舒张试验阳性是什么意思| 什么是对称轴| 头菜是什么菜| 尿蛋白低是什么原因| 肝郁脾虚吃什么中成药| 郁结是什么意思| 梦见晒被子是什么意思| 社保基金是什么| 9月3号是什么纪念日| 言过其实是什么意思| 30如狼40如虎是什么意思| 乳腺b超挂什么科| 阴囊湿疹长什么样图片| 基数是什么意思| 为什么外阴老是长疖子| 乾隆是什么朝代| 辛卯五行属什么| 戒断反应是什么| 便秘吃什么药效果最好| 低头头晕是什么原因| 宝宝佛适合什么人戴| 有胃火口臭怎么办吃什么药| 慧眼识珠是什么意思| 蛇喜欢吃什么食物| 无性恋是什么| 苹果代表什么生肖| 什么样的你| 小孩干咳是什么原因| 五行什么生火| 乳腺b超挂什么科| 胃酸胃胀反酸水吃什么药| 胸是什么| 马后面是什么生肖| 梦到和婆婆吵架是什么意思| 姑息什么意思| 微凉是什么意思| 夜间睡觉流口水是什么原因| 四川人喜欢吃什么| 空调外机很响是什么原因| 受割礼是什么意思| 尘埃落定什么意思| 身体水肿是什么原因引起的| 阴唇长什么样| 急性肠胃炎吃什么消炎药| 男生来大姨夫是什么意思| 纳采是什么意思| 手肿脚肿是什么原因引起的| 半夜口干舌燥是什么原因| 骨髓水肿是什么意思| 曲马多是什么| 眼睛模糊吃什么药| 血糖是什么引起的| 右耳鸣是什么原因| 中国的国果是什么| 杰字五行属什么| 李子为什么不能多吃| 沉香是什么东西| 发挥失常是什么意思| dostinex是什么药| 风水宝地是什么意思| 热锅上的蚂蚁是什么意思| 紫癜吃什么药| 人流后可以吃什么| 为什么叫深圳| 中将相当于什么级别| 什么是情劫| 长脸适合什么眼镜框| 最新奥特曼叫什么| 2000年属什么生肖| 川芎治什么病最好| 王毅什么级别| 笑点低的人说明什么| 生蚝什么时候最肥| 什么是二次元| 什么是微创手术| 娇羞是什么意思| 与世隔绝的绝是什么意思| 胡萝卜什么时候成熟| 社会很单纯复杂的是人是什么歌| 结婚12年是什么婚| 耿直是什么意思| 组织细胞是什么| 为什么医者不自医| 体寒吃什么| 打呼噜吃什么药最管用| 为什么一直拉肚子| 贫血有什么危害| 肚子疼拉肚子挂什么科| 鱼胶是什么| 邪淫是什么意思| 佛家思想的核心是什么| 中国梦是什么梦| 大肠头是什么部位| 入盆是什么意思| 1.11是什么星座| 女人性冷淡吃什么药| 梦见到处都是蛇预示着什么| 橘色五行属什么| 翊是什么意思| 脾胃湿热什么症状| 耳朵疼是什么原因| 1207是什么星座| 青蛙趴有什么好处| 名媛是什么意思| 苦涩是什么意思| 颈椎疼挂什么科室| 老是头晕是什么原因| 当归长什么样| 健脾吃什么食物| 子宫切除对女人有什么影响| 烂脚丫用什么药最好| 为什么放生泥鳅果报大| 什么叫智慧| 产后什么时候来月经正常| 中药什么时间喝效果最好| 谷丙转氨酶高吃什么药可以降下来| 赵匡胤为什么不传位给儿子| 柯什么意思| 男朋友昵称叫什么好听| 小肚子疼是什么原因| 9月20号是什么星座| 鼻孔流血是什么原因| 荨麻疹可以涂什么药膏| 心肾两虚吃什么中成药| 两个月没有来月经了是什么原因| 空姐在飞机上干什么| 洗面奶和洁面乳有什么区别| 什么闻乐见| 查血糖是什么检查项目| 痔疮用什么药效果好| 兰花什么时候开花| 空调制冷量是什么意思| hla一b27阳性是什么意思| 湿气重吃什么中药好| 胎停了有什么明显症状| pola是什么牌子| 百利甜酒兑什么最好喝| 胎儿右侧脉络丛囊肿是什么意思| 什么样的月光| 乳头经常痒是什么原因| 做糖耐前一天需要注意什么| 细菌感染发烧吃什么药| 梦见娃娃是什么意思| 膝盖后面叫什么部位| 梦见自己会飞是什么意思| 拿什么东西不用手| cmb是什么意思| 九月三号是什么星座| 巨石强森是什么人种| 降调针什么时候打| 编程是干什么的| 什么叫热射病| 可怜巴巴是什么意思| 骑马挥杆是什么牌子| 过敏性鼻炎喝什么茶好| 什么是格林巴利综合症| 感冒吃什么食物| 吃什么盐比较好有利于健康| 什么季节补钙效果最好| 乳腺结节什么症状表现| 灰指甲是什么样子的| 什么门永远关不上| 香水什么味道好闻| 拉油便是什么原因| 口干舌燥口苦吃什么药| 女人熬夜吃什么抗衰老| 女性尿酸低是什么原因| 世界上最贵的车是什么车| 高血压看什么科| 脂肪瘤去医院挂什么科| 和胃降逆是什么意思| 膀胱炎挂什么科| 洋葱有什么好处| 敦促的意思是什么| 烧酒是什么酒| 百度

体育竞技--贵州频道--人民网

FDA
Aug 4, 2025, 20:16 | Science
Tanja Obradovic: Jaypirca vs Imbruvica - Promising Phase 3 Data in CLL/SLL
Tanja Obradovic, Oncology Medical Strategy Advisor at Mercurial AI, shared a post on LinkedIn: "Few…
Aug 4, 2025, 18:11 | Blog
Steve Harvey: Ever Wondered About Monoclonal Antibody Applications?
Steve Harvey, CEO at Camena Bioscience, shared on LinkedIn: "Ever wondered about monoclonal antibody applications?…
Aug 4, 2025, 15:44 | Blog
Tanja Obradovic: Path to Delivering Optimal Dose of the New Drug to Cancer Patients is Complex
Tanja Obradovic, Oncology Medical Strategy Advisor at Mercurial AI, shared on LinkedIn: "Path to delivering…
Aug 4, 2025, 11:31 | Blog
Kevin Harrington: Open Letter to the FDA
Kevin Harrington, Professor in Biological Cancer Therapies at Institute of Cancer Research, shared on LinkedIn:…
Aug 2, 2025, 06:29 | Drugs
Telisotuzumab vedotin (Emrelis) Updates 2025: Uses in Cancer, Dosage, Side Effects, Expectations, and More
Telisotuzumab vedotin is an innovative antibody-drug conjugate (ADC) designed to target and attack cancer cells…
Aug 1, 2025, 20:57 | Blog
Al-Ola A Abdallah: Why Vinay Prasad left the FDA?
Al-Ola A Abdallah, Director of Plasma Cell Disorder Program at the University of Kansas Medical…
Aug 1, 2025, 18:53 | Blog
Marty Makary: Looking Forward to FDA National Listening Tour with Pharmaceutical and Biotech CEOs
Marty Makary, 27th Commissioner of the U.S. FDA, shared a post by FDA, adding: "Looking…
Aug 1, 2025, 16:21 | Blog
Luis Raez: 3 INDs Approved for Patients with HER2 Mutations and Lung Cancer
Luis Raez, Medical Director and Chief Scientific Officer at Memorial Cancer Institute, shared a post…
Jul 30, 2025, 20:38 | Blog
Kevin Harrington: I Share a Letter Sent by Professor Axel Hauschild to the FDA Commissioner
Kevin Harrington, Professor in Biological Cancer Therapies at Institute of Cancer Research, shared on LinkedIn:…
Jul 28, 2025, 08:44 | Blog
Applications are Open for the FDA-AACR Oncology Educational Fellowship
American Association for Cancer Research (AACR) shared a post on LinkedIn: "The FDA-AACR Oncology Educational…
Jul 28, 2025, 08:34 | Blog
Mohit Manrao: FDA Grants Priority Review for sBLA in Resectable Early-Stage Gastric and GEJ Cancers
Mohit Manrao, SVP, Head of US Oncology at AstraZeneca, shared a post on LinkedIn: "This…
Jul 27, 2025, 08:17 | Drugs
Darolutamide (Nubeqa) 2025 Updates: A Patient Guide to Treatment for Prostate Cancer
Darolutamide is a medicine used to treat certain types of prostate cancer. It works by…
Jul 25, 2025, 15:58 | Blog
Optimizing Dosage Selection Strategies in Oncology - ASCO
American Society of Clinical Oncology (ASCO) shared a post on LinkedIn: "A new report calls…
Jul 24, 2025, 20:30 | Blog
Appplications for FDA-AACR Oncology Educational Fellowship Are Open - American Association for Cancer Research
American Association for Cancer Research (AACR) shared a post on LinkedIn: "The FDA-AACR Oncology Educational…
Jul 23, 2025, 18:03 | Insight
E. Shyam P. Reddy: Two Cancer Medications that Could Treat the most Common Form of Dementi
E. Shyam P. Reddy, Professor and Director of the Cancer Biology Program at Morehouse School…
Jul 23, 2025, 10:05 | Drugs
Linvoseltamab (Lynozyfic) Approved for Myeloma: Key 2025 Updates for Patients
Linvoseltamab-gcpt is a newly approved cancer treatment for adults with relapsed or refractory multiple myeloma.…
Jul 23, 2025, 08:10 | Drugs
Linvoseltamab (Lynozyfic) 2025 Updates: Uses in Cancer, Dosage, Side Effects, Expectations, and More
Linvoseltamab is a recently approved cancer treatment that represents a new wave of innovation in…
Jul 19, 2025, 07:22 | Drugs
Datopotamab deruxtecan-dlnk (Datroway) 2025 Guides: What Patients Need to Know?
Datopotamab deruxtecan-dlnk is a new type of targeted cancer therapy known as an antibody-drug conjugate…
Jul 19, 2025, 00:34 | Insight
Hung Trinh: Bispecific Antibodies in Solid Tumors
Hung Trinh, Senior VP of Operations at Seneca Therapeutics, shared a post on LinkedIn: "Bispecific…
Jul 17, 2025, 06:28 | Drugs
Dostarlimab (Jemperli) 2025 Updates: Uses in Cancer, Side Effects, Dosage, Expectations, and More
Dostarlimab, sold under the brand name Jemperli, is a type of cancer immunotherapy known as…
Jul 16, 2025, 13:40 | Blog
FDA Warns Companies Illegally Marketing Products Containing 7-OH
U.S. FDA shared a post on X: "Today, we announced the issuance of seven warning…
Jul 15, 2025, 18:22 | Blog
Marty Makary: We Should Never Miss a Big Safety Issue - Much Less Wait 20 Years to See It
Marty Makary, 27th Commissioner of the U.S. FDA, shared on X: "We need to have…
Jul 15, 2025, 14:26 | Blog
The FDA-AACR Oncology Educational Fellowship
American Association for Cancer Research (AACR) shared a post on LinkedIn: "The FDA-AACR Oncology Educational…
Jul 13, 2025, 14:37 | Blog
Marty Makary: Bringing Transparency in FDA decisions
Marty Makary, 27th Commissioner of the U.S. FDA, shared a post on?X: "Transparency in FDA…
Jul 13, 2025, 11:56 | Insight
Susana Banerjee: First Approved Therapy for Low Grade Serous Ovarian Cancer
Susana Banerjee, Professor in Women's Cancers at The Institute of Cancer Research, shared on X:…
Jul 13, 2025, 11:38 | Blog
Marty Makary: A Special 100-day Milestone FDA Direct
Marty Makary, 27th Commissioner of the U.S. FDA, shared a post on X: "Just wrapped…
Jul 13, 2025, 05:33 | Blog
Pat Soon-Shiong: It’s Time For the Modernization of The FDA
Pat Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman ImmunityBio, Executive Chairman of Los…
Jul 13, 2025, 00:47 | Blog
Luciano J Costa: Most Innovation in Multiple Myeloma is from China
Luciano J Costa, Professor at University of Alabama at Birmingham, shared a post on X:…
Jul 12, 2025, 17:14 | Blog
Agenus Responds to New Regulatory Environment at FDA
Agenus posted on LinkedIn: "This morning on CNBC's Squawk Box, FDA Commissioner Dr. Marty Makary,…
Jul 11, 2025, 15:18 | Insight
Marty Makary: FDA Has Published More than 200 Complete Response Letters
Marty Makary, 27th Commissioner of the U.S. FDA, shared a post on LinkedIn: "Today, we're…
Jul 11, 2025, 09:46 | Blog
Wafik El-Deiry: ONC201 has been Shrinking Aggressive Brain Tumors in Clinical Trials
Wafik El-Deiry, Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director…
Jul 9, 2025, 20:09 | Blog
Tanja Obradovic: FDA's Review of RP1 for Relapsed/Refractory Melanoma and the Challenges of Launching New Cancer Therapies
Tanja Obradovic, Oncology Medical Strategy Advisor at Mercurial AI, shared a post on LinkedIn: "Among…
Jul 8, 2025, 18:55 | Drugs
Miguel Bronchud: Who Pays for New Drugs?
Miguel Bronchud, Co-Founder and Advisory Board at Regenerative Medicine Solutions, shared a post on LinkedIn:…
Jul 8, 2025, 17:57 | Drugs
Maria Babak: A Meaningful Step Forward for ROS1-Positive NSCLC
Maria Babak, Head of The Babak Lab and Assistant Professor at City University of Hong…
Jul 6, 2025, 06:20 | Blog
Giovanni Maria Iannantuono: What about cancer patients with poor functional status?
Giovanni Maria Iannantuono, Medical Oncologist at Fondazione Policlinico Universitario Agostino Gemelli IRCCS, shared a post…
Jul 5, 2025, 15:54 | Drugs
Tafasitamab-cxix (Monjuvi): What Patients Need to Know About-2025 Updates
Tafasitamab-cxix is a targeted immunotherapy approved for treating certain aggressive B-cell lymphomas. Backed by the…
Jul 5, 2025, 13:32 | Blog
Al-Ola A Abdallah: Why is Belantamab Mafodotin Called a “Trojan Horse” in Myeloma?
Al-Ola A Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of…
Jul 4, 2025, 14:56 | Insight
Mariam Alexander: More Options for NSCLC with EGFR Exon 20 Insertion Mutation
Mariam Alexander, Thoracic Medical Oncologist at MUSC Health University Medical Center, shared a post on…
Jul 4, 2025, 02:17 | Blog
Joshua Richter: Linvoseltamab-gcpt Receives FDA Accelerated Approval for Multiple Myeloma
Joshua Richter, Associate Professor of Medicine, Hematology, and Medical Oncology at The Tisch Cancer Institute,…
Jul 2, 2025, 01:06 | Science
FDA Oncology News: June 2025 Updates
The U.S. Food and Drug Administration (FDA) is a federal agency within the Department of…
Jun 30, 2025, 08:58 | Insight
Rahul Banerjee: Excellent News - FDA Eliminates REMS Across CAR-T Products for US Patients
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center at the University of Washington, shared…
Jun 29, 2025, 08:37 | Blog
Ajay Major: No more REMS for FDA-approved CAR-T products
Ajay Major, Founder and President of Pager Publications and Assistant Professor of Medicine at the…
Jun 26, 2025, 07:39 | Blog
Nancy Lee on Designing Pembrolizumab Trial for Head and Neck Cancer and FDA Approval
Memorial Sloan Kettering Cancer Center shared on X: "The FDA has approved the immunotherapy drug…
Jun 26, 2025, 06:06 | Blog
Listen to the New Episode of Lung Cancer Considered on the FDA Approval of Taletrectinib for ROS1-Positive NSCLC - IASLC
International Association for the Study of Lung Cancer shared a post on LinkedIn: "The FDA…
Jun 25, 2025, 20:47 | Insight
Saadvik Raghuram Y: FDA Approves Talectrectinib for ROS1-Positive Locally Advanced or Metastatic NSCLC
Saadvik Raghuram Y, Head of Department of Medical Oncology at Arete Hospitals, shared a post…
Jun 25, 2025, 07:53 | Oncolibrary
FDA Grants Accelerated Approval to Datopotamab Deruxtecan-dlnk for EGFR-Mutated Non-Small Cell Lung Cancer
On June 23, 2025, the U.S. Food and Drug Administration (FDA) granted accelerated approval to…
Jun 24, 2025, 07:38 | Blog
Aakash Desai: FDA Accelerated Approval of Datopotamab Deruxtecan for EGFRm NSCLC
Aakash Desai, Assistant Professor and Associate Director of Phase 1 and Precision Oncology Program at…
Jun 21, 2025, 15:10 | Blog
U.S. FDA Publishes White Paper on Cybersecurity in Medical Product Manufacturing Technologies
U.S. FDA posted on X: "The FDA just published a white paper bringing attention to…
Jun 20, 2025, 13:38 | Insight
Yan Leyfman: FDA Approves Yeztugo, a Game-Changing HIV Prevention Drug
Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn: "Historic…
Jun 18, 2025, 08:27 | Insight
Marty Makary: The Power Of AI and Big Data To Revolutionize Our Approach?at?the?FDA
Marty Makary, 27th Commissioner of the U.S. FDA, shared a post on X: "Pleased to…
Jun 17, 2025, 06:18 | Insight
Aakash Desai Shared A Study Published In JTO on Datopotamab Deruxtecan In Patients With EGFR-mutated NSCLC
Aakash Desai, Assistant Professor and Associate Director of Phase 1 and Precision Oncology Program at…
Jun 16, 2025, 11:01 | Insight
AI In Medicine: Top 3 Advances This Week Suggested by?Samuel?Hume
Samuel Hume, Fellow at The Foulkes Foundation and pursuing PhD in the University of Oxford’s…
Jun 15, 2025, 05:32 | Blog
FDA's Office of Clinical Pharmacology Released 2024 Annual Report
U.S. FDA shared a post on X: "FDA's Office of Clinical Pharmacology announces the availability…
Jun 14, 2025, 14:44 | Insight
Vivek Subbiah: Why Every Rare Cancer Patient Deserves Molecular Profiling?
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a…
Jun 14, 2025, 12:47 | Insight
Amol Akhade shared an article: FDA Approves Perioperative Pembrolizumab Plus Radiation in HNSCC
Amol Akhade, Consultant Medical Oncologist at Suyog Cancer Clinics, shared his post on X: "And…
Jun 13, 2025, 08:21 | Insight
Dr. Marty Makary Outlines Bold New Priorities for Tackling Chronic Disease and Accelerating Cures - FDA
U.S. FDA shared a post on X: "The new FDA has bold priorities! Dr. Marty…
Jun 13, 2025, 07:19 | Blog
Misako Nagasaka Shares FDA Approval of Taletrectinib for ROS1-Positive NSCLC
Misako Nagasaka, Thoracic Oncologist at University of California Irvine, posted on X: "Another option for…
Jun 13, 2025, 04:16 | Drugs
Pemigatinib (Pemazyre): Uses in Cancer, Side effects, Dosage, Expectation and more
Pemigatinib is a type of targeted cancer treatment that works by blocking abnormal FGFR (fibroblast…
Jun 12, 2025, 19:16 | Insight
Eric K. Singhi: U.S. FDA Approved Taletrectinib for ROS1+ mNSCLC
Eric K. Singhi, Thoracic Medical Oncologist at MD Anderson Cancer Center, shared a post on…
Jun 12, 2025, 19:07 | Insight
Rami Manochakian: FDA Approves Taletrectinib for ROS1-Positive Non-Small Cell Lung Cancer Based on TRUST Trials
Rami Manochakian, Vice President of the North American Neuroendocrine Tumor Society, shared on X: "Hot…
Jun 12, 2025, 06:49 | Blog
Marty Makary: Discussing Fresh Ideas and Priorities for a New FDA
Marty Makary, 27th Commissioner of the U.S. FDA, shared a post on X: "While the…
Jun 10, 2025, 19:16 | Insight
Francisco J. Esteva: Can PROTACs Beat ESR1 Mutations in Breast Cancer?
Francisco J. Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill…
Jun 10, 2025, 11:37 | Drugs
Futibatinib (Lytgobi): What patients need to know?
Futibatinib is a targeted cancer treatment developed by Taiho Oncology. In 2022, it received FDA…
Jun 10, 2025, 03:46 | Drugs
Futibatinib (Lytgobi): Uses in Cancer, Side Effects, Dosage, Expectations, and More
Futibatinib is a targeted cancer therapy that inhibits FGFR2, a protein involved in tumor growth…
Jun 8, 2025, 21:13 | Blog
Modernizing Regulatory Pathways for Faster Access to CGT Breakthroughs - Parker Institute for Cancer Immunotherapy
Parker Institute for Cancer Immunotherapy shared a post on X: ''How do we modernize regulatory…
Jun 8, 2025, 06:06 | Insight
Martin Makary Shared Insights from FDA Cell and Gene Therapy Roundtable
Martin Makary, 27th Commissioner of the U.S. FDA, shared a post on X by U.S.…
Jun 6, 2025, 01:31 | Blog
Abner Antonio Murray: Duaa Kanan’s Groundbreaking AI Pipeline for NSCLC Therapy at ASCO25
Abner Antonio Murray, Hematology/Oncology Fellow at UNC School of Medicine, shared a post by FlorezLab,…
Jun 5, 2025, 09:01 | Blog
Alicia Zhou: Introducing the 2025 CRI Cancer Immunotherapy Insights + Impact Report
Alicia Zhou, CEO at Cancer Research Institute, shared a post on LinkedIn: "I’m so thrilled…
Jun 4, 2025, 10:43 | Blog
The First-Ever AI Tool that Predicts a Woman’s Breast Cancer Risk over the following 5 year - The Breast Cancer Research Foundation
The Breast Cancer Research Foundation?shared a post on LinkedIn: "The FDA just approved Clairity Breast,…
Jun 2, 2025, 09:10 | Science
The Institute of Cancer Research Announces FDA Approval of First Therapy for Low-Grade Serous Ovarian Cancer
The Institute of Cancer Research shared a post on LinkedIn: "NEW: The FDA has granted…
Jun 1, 2025, 08:52 | Drugs
LUNGevity Foundation Highlighted FDA Approval on Telisotuzumab Vedotin (EMRELIS) in Advanced NSCLC
LUNGevity Foundation shared a post on LinkedIn: "Despite the progress we have seen in the…
May 30, 2025, 10:47 | Blog
Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at?ESMO-GI?2025
Richard Goldberg, Chief Development Officer at Agenus, shared a post on LinkedIn: "As many of…
May 29, 2025, 20:53 | Blog
Jasmine Kamboj Congratulated Jonathan Ticku for FDA ODAC Testimony on Daratumumab
Jasmine Kamboj, Medical Oncologist and Hematologist at the Mayo Clinic, shared a post on LinkedIn…
May 28, 2025, 05:38 | Drugs
Sorafenib (Nexavar): What patients need to know?
Sorafenib is a targeted cancer treatment taken as a tablet. It has been approved by…
May 25, 2025, 15:54 | Blog
Martin Makary on the Disparity Between Medical Innovation and Public Health Progress
Martin Makary, 27th Commissioner of the U.S. FDA, posted on X: "In the terms of…
May 24, 2025, 19:13 | Drugs
Amol Akhade on ODAC’s unanimous vote against Talazoparib + Enzalutamide for non-HRRm mCRPC
Amol Akhade, Consultant Medical Oncologist at the Suyog Cancer Clinics, shared a post on LinkedIn:…
May 23, 2025, 08:08 | Drugs
Eribulin (Halaven): Uses in Cancer, Side effects, Dosage, Expectations, and more
Eribulin is an anticancer chemotherapy agent classified as a microtubule dynamics inhibitor and structurally related…
May 22, 2025, 17:38 | Blog
Zacharoula Sidiropoulou: Are the Treatments We Prescribe to Our Most Vulnerable Patients Actually Tested On Them?
Zacharoula Sidiropoulou, Senior Consultant Breast Surgical Oncologist at Hospital S?o Francisco Xavier, shared a post…
May 22, 2025, 06:38 | Blog
Aakash Desai: A summary of 'What Biopharma Should Learn'
Aakash Desai,?Assistant Professor and Associate Director of Phase 1 and Precision Oncology Program at the…
May 21, 2025, 19:04 | Insight
FDA and HHS announced next steps in Operation Stork Speed for infant formula nutrition standards
U.S. FDA shared a post on X: "Today, U.S. Department of Health and Human Services…
May 21, 2025, 17:12 | Insight
Tanja Obradovic: Issue of Trial Data Applicability to US Patient Population is Resurfacing Again at FDA
Tanja Obradovic, Oncology Medical Strategy Advisor at Mercurial AI, shared a post on LinkedIn: "Issue…
May 20, 2025, 09:22 | Drugs
Pluvicto (177Lu-PSMA-617): What patients need to know?
Pluvicto (lutetium Lu 177 vipivotide tetraxetan) is a targeted radioligand therapy used for treating advanced…
May 19, 2025, 18:59 | Blog
90% of kids don’t get their daily intake of vegetables - FDA
FDA shared on LinkedIn: "70% of our food is from ultra-processed sources. 50% of kids…
May 18, 2025, 11:29 | Blog
FDA Commissioner Martin Makary Hosted Kyle Diamantas and Sanjula Jain-Nagpal on FDA Direct Podcast Episode 2
U.S. Food and Drug Administration (FDA)?shared a post on LinkedIn: "70% of our food is…
May 18, 2025, 05:14 | Drugs
Pluvicto (177Lu-PSMA-617): Uses in Cancer, Side Effects, Dosage, Expectations, and More
Pluvicto (lutetium Lu 177 vipivotide tetraxetan) is a targeted radioligand therapy used to treat advanced…
May 17, 2025, 21:36 | Blog
Nicholas Hornstein: New FDA Approval for Metastatic Anal Cancer
Nicholas Hornstein, Assistant Professor at Northwell Health, shared on X: "New FDA approval for metastatic…
May 17, 2025, 06:57 | Science
Amol Akhade: First and Only Approved 1st-Line Immunotherapy For Advanced SCAC (Anal Cancer) in the U.S.
Amol Akhade, Senior Consultant Medical Oncologist and Hemato-Oncologist at Suyog Cancer Clinics and Reliance Hospitals…
May 16, 2025, 21:18 | Opinion
Martin Makary Applauds FDA Clearance of First Blood Test for Alzheimer’s Diagnosis
Martin Makary, 27th Commissioner of the U.S. FDA, shared FDA's post on X: "Alzheimer’s disease…
May 16, 2025, 17:35 | Insight
Amol Akhade: A New Era for Advanced Anal Cancer Treatment
Amol Akhade, Senior Consultant Medical Oncologist and Hemato-Oncologist at Suyog Cancer Clinics and Reliance Hospitals,…
May 16, 2025, 13:21 | Oncolibrary
FDA Approves Retifanlimab-dlwr with Chemotherapy and as Monotherapy for Advanced Squamous Cell Carcinoma of the Anal Canal
On May 15, 2025, the U.S. Food and Drug Administration (FDA) approved retifanlimab-dlwr (Zynyz, Incyte…
May 16, 2025, 06:13 | Blog
IASLC - FDA Accelerated Approval of Emrelis for Advanced NSCLC
International Association for the Study of Lung Cancer (IASLC) posted on LinkedIn: "FDA Accelerated Approval…
May 16, 2025, 02:14 | Blog
Rob Michael Announces FDA Approval of AbbVie’s New NSCLC Therapy
Rob Michael, Chief Executive Officer of AbbVie, posted on LinkedIn: "Today, the U.S. FDA announced…
May 15, 2025, 15:02 | Blog
Martin Makary Discusses the Current and Future Happenings at the FDA on the FDA Direct podcast
U.S. FDA shared a post on X: "Our new podcast, FDA Direct, gives you a…
May 15, 2025, 14:19 | Blog
FDA Approves the First Oral Treatment for Pheochromocytoma and Paraganglioma - FDA Oncology
FDA Oncology?shared a post on X: "FDA approves the first oral treatment for pheochromocytoma and…
May 15, 2025, 12:43 | Blog
The Role of IHC Expanding the List of Potential Targets - Caris Life Sciences
Caris Life Sciences?shared a post on LinkedIn: "Join our upcoming webinar to learn how Caris…
May 15, 2025, 05:24 | Blog
Aakash Desai: Another ADC lands in lung cancer
Aakash Desai,?Assistant Professor and Associate Director of Phase 1 and Precision Oncology Program at the…
May 14, 2025, 18:42 | Oncolibrary
FDA Grants Accelerated Approval for Telisotuzumab Vedotin (EMRELIS?) in c-MET–Overexpressing Advanced Non-Small Cell Lung Cancer
On May 14, 2025, the U.S. Food and Drug Administration (FDA) granted accelerated approval for…
May 14, 2025, 13:48 | Blog
FDA's 'Project Interface' to provide outreach and engagement
Tanja Obradovic,?Vice President of Oncology Scientific Affairs at ICON PLCh, shared a post on LinkedIn:…
May 14, 2025, 06:22 | Drugs
Martin Makary: FDA Takes Action to Remove Concentrated Ingestible Fluoride Prescription Drug Products for Children
Martin Makary, 27th Commissioner of the U.S. FDA, shared a post on?X: "Today, the FDA…
May 11, 2025, 08:20 | Blog
Matthew Oberley: Educational Webinar on the Role of IHC in Expanding Potential Targets
Matthew Oberley, Chief Clinical Officer of Caris Life Sciences, shared a post on LinkedIn: "As…
All: 623 Posts: 1 - 100
Special Coverage
成因是什么意思 为什么今年夏天特别热 拔牙后吃什么食物最好 血小板偏低有什么危害 脾胃不好吃什么水果好
什么叫裸眼视力 什么的秋天 宋字五行属什么 破伤风什么症状 喉结下面是什么部位
白带是绿色的是什么原因 为什么回族不吃猪肉 甲沟炎看什么科室 像什么似的 规培护士是什么意思
oversize风格什么意思 梦见洗衣服是什么意思 乐高是什么 脚背痒是什么原因 三焦湿热吃什么中成药
小孩睡觉趴着睡是什么原因hcv9jop5ns2r.cn 为什么会口臭的原因wzqsfys.com 配裙子穿什么鞋子好看gangsutong.com 梦见苹果是什么意思hcv7jop6ns6r.cn 冷得什么travellingsim.com
绿心黑豆有什么功效hcv8jop5ns3r.cn 什么是外围hcv8jop1ns2r.cn 1288是什么意思hcv8jop1ns5r.cn 血浓稠是什么原因引起的hcv8jop1ns3r.cn 人生开挂是什么意思hcv8jop3ns7r.cn
愚不可及是什么意思hcv9jop6ns9r.cn 每逢佳节倍思亲的上一句是什么hcv8jop7ns9r.cn 大姨妈推迟什么原因hcv8jop1ns8r.cn 肺上有结节是什么意思hcv9jop2ns8r.cn 易烊千玺的爸爸是干什么的hcv7jop4ns8r.cn
孕妇梦见大蟒蛇是什么意思hcv8jop5ns4r.cn 蓟是什么意思520myf.com sample是什么意思hcv8jop8ns5r.cn 蜘蛛痣是什么原因引起的hcv9jop4ns9r.cn 梦见瓜是什么意思hcv8jop7ns9r.cn
百度